Salim Janmohamed, MD

GSK, Brentford, UK
Brentford, England, United Kingdom

Disclosure(s): GSK: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 512 - Efficacy of Gepotidacin versus Nitrofurantoin in a Nitrofurantoin Not Susceptible Population: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection

  Saturday, October 19, 2024
  11:06 AM – 11:18 AM US PT